Comparing stomach cancer and brain metastasis genetics
Part of Brain & nervous system, Cancer, Digestive system clinical trials.
This trial studies stomach and esophageal cancers that spread to the brain. It compares the genetic makeup of the original tumor to the brain metastasis, which may help find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and part of the GASTROBRAIN study, with your medical records available.
- You have been diagnosed with stomach cancer, esophageal cancer, or cancer where the stomach meets the esophagus.
- You had brain metastases surgically removed, and that tissue is still available for study.
- Tissue samples from both your primary tumor and your brain metastasis are available for comparison.
- You do not have any other type of cancer (other than the one in your stomach or esophagus).
- The brain tumor must be in the brain tissue itself, not just in the skull bones or head soft tissues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
This trial uses brain MRI scans and deep learning to predict whether non-small cell lung cancer that has spread to the brain has certain gene changes (EGFR or ALK). Knowing this may help guide treatment without needing additional tissue testing.
This trial tests tumor samples from brain metastases to see which drug might work best for you. It aims to guide your next treatment when standard options are limited.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study follows patients with stomach cancer that has spread to the liver to learn more about their health over time. It may help doctors understand how to better care for people with this condition.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.